Global IVD Regulatory Affairs Outsourcing Market is growing with factors such as rise in the prevalence of chronic diseases across the region. Technological advancement in various in vitro diagnostic devices acts as a major factor for the growth of the market. Development of project based support leads to long term outsourcing agreement among organization have also given a boom to the global IVD regulatory affairs outsourcing market.
Increase in product registration numbers and clinical trial approvals across the region have propelled the demand of the market. However, higher cost related to maintenance and outsourcing of IVD may decreased the demand in the market.
Global IVD Regulatory Affairs Outsourcing Market Scenario
According to Data Bridge Market Research, the global IVD regulatory affairs outsourcing market in North America has the highest market share the market leader is ICON plc, which accounts an estimated market share of approximately 17.88% in the global market. The company has gained outstanding sale by providing multiple IVD regulatory affairs outsourcing services and solutions.
- In July 2021, ICON acquisition created world-leading healthcare intelligence and clinical research organization. This acquisition enhanced operations to transform clinical trials and accelerate biopharma customer’s commercial success through the development of much needed medicines and medical devices. This has helped company to improve its position in market.
Trends Impacting the Market
Now the question is which other regions ICON plc, Medpace and Parexel International Corporation are targeting? Data Bridge Market Research has forecast large growth in North America IVD regulatory affairs outsourcing market and the market leaders are targeting U.S., Canada and Mexico to be their next picket revenue in 2022.
The IVD regulatory affairs outsourcing market is becoming more competitive with companies such as ICON plc, Medpace and Parexel International Corporation. These are the top dominating companies in IVD regulatory affairs outsourcing market and have launched novel products in the market. The data bridge market research new reports highlight the major growth factors and opportunities in the global IVD regulatory affairs outsourcing market.
For more analysis on the global IVD regulatory affairs outsourcing market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-ivd-regulatory-affairs-outsourcing-market
IVD Regulatory Affairs Outsourcing Market Developments
- In February 2021, ICON acquired PRA Health Sciences for creating a world leader in Healthcare Intelligence and Clinical Research. Company entered into a definitive agreement to acquire PRA Health Sciences, Inc. This acqusition lead to develop high-quality, innovative and growing organisations with similar cultures and a shared focus on high quality and efficient clinical trial execution from Phase 1 to post-approval studies. This has helped company to improve its position in market.
- In February 2021, Medpace partnered with Greenleaf, a leading FDA regulatory consulting firm based in Washington DC. It comprised of experts with a combined total of more than 300 years of FDA experience to enhance strategic regulatory affairs capabilities. Greenleaf’s comprehensive services and wealth of experience helps to deliver regulatory strategies for sponsors through the lens of the FDA. This has help the company to expand their business and market position
- In October 2021, Parexel International Corporation and Kyoto University Hospital Announcea Strategic Alliance for supporting clinic studies. Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health, and Kyoto University Hospital announced a strategic alliance aimed at providing more opportunities for clinical research and producing efficient and productive ways of supporting clinical studies. This has helped company to improve its focus on development and research.
Scope of the IVD Regulatory Affairs Outsourcing Market
- On the basis of countiers global IVD regulatory affairs outsourcing market is segmented into U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Switzerland, Russia, Turkey, Belgium, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, Saudi Arabia, South Africa, U.A.E., Egypt, Israel and Rest of Middle East and Africa, Brazil, Argentina, & Rest of South America.
All country based analysis of the global IVD regulatory affairs outsourcing market is further analyzed based on maximum granularity into further segmentation. On the basis of services, the global IVD regulatory affairs outsourcing market is segmented into regulatory writing & submissions, regulatory registration & clinical trial applications, regulatory consulting, legal representation, data management services, chemistry manufacturing and controls (CMC) services, and others. On the basis of indication, the global IVD regulatory affairs outsourcing market is segmented into oncology, neurology, cardiology, clinical chemistry and immunoassays, precision medicine, infectious diseases, diabetes, genetic testing, HIV/AIDS, haematology, drug testing/pharmacogenomics, blood transfusion, point of care, and others. On the basis of deployment mode, the global IVD regulatory affairs outsourcing market is segmented into cloud and on-premises. On the basis of organization size, the global IVD regulatory affairs outsourcing market is segmented into small and medium enterprises (SMES) and large enterprises. On the basis of stage, the global IVD regulatory affairs outsourcing market is segmented into clinical, preclinical, and PMA (post-market authorization). On the basis of class, the global IVD regulatory affairs outsourcing market is segmented into class I, class II, and class III. On the basis of end user, the global IVD regulatory affairs outsourcing market is segmented into pharmaceutical companies, medical device companies, biotechnology companies, and others.
To know more about the study https://www.databridgemarketresearch.com/reports/global-ivd-regulatory-affairs-outsourcing-market
Key Pointers Covered in IVD Regulatory Affairs Outsourcing Market Industry Trends and Forecast to 2029
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
- Market value and over view of IVD regulatory affairs outsourcing market
- Company profiling of top eight players of IVD regulatory affairs outsourcing market
Key Market Competitors Covered in the Report
- Freyr Solutions
- AXSource
- LORENZ Life Sciences Group
- PPD Inc. (A Subsidiary of Thremofisher Scientific Inc.)
- Promedica International, a California Corporation
- Assent Compliance Inc.
- MakroCare
- EMERGO
- ICON
- Parexel International Corporation
- CRITERIUM, INC.
- Groupe ProductLife S.A.
- Propharma Group
- VCLS
- Labcorp Drug Development
- WuXi AppTec
- Charles River Laboratories
- Genpact
- Medpace
- Andaman Medical
- Asia Actual
- Regulatory Compliance Associates Inc.
- RQM+
- Saraca Solutions Private Limited
- PBC BioMed
- Dor Pharmaceutical Services
- Qserve
- MARACA International BVBA
- mdiConsultants, Inc.
Above are the key players covered in the report, to know about more and exhaustive list of IVD regulatory affairs outsourcing companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-ivd-regulatory-affairs-outsourcing-market
Research Methodology: Global IVD Regulatory Affairs Outsourcing Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Manufacturer, Product Developers, Commercial Buyers, Residential Buyers and Retailers among others.
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Related Reports
- Global Immuno In-Vitro Diagnostics (IVD) Market – Industry Trends and Forecast to 2028
- Global In Vitro Diagnostics (IVD) Quality Control Market – Industry Trends and Forecast to 2029
- Global In Vitro Diagnostics (IVD) Quality Control Market – Industry Trends and Forecast to 2029
- Global Medical Device Regulatory Affairs Outsourcing Market – Industry Trends and Forecast to 2028
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
